Workshop A: Optimizing Biomarker Use in Innate Immune System Targeted Therapies to Streamline Patient Stratification & Response Assessment Within Clinical Trials
Time: 4:35 pm
day: Conference Day 1
Details:
This workshop aims to delve into the critically useful role of biomarkers in therapies targeting the innate immune system, specifically focusing on STING & TLR receptors. Attendees will gain insights into utilizing biomarkers for patient stratification, assessing treatment response, and addressing the evolving landscape of biomarker integration into clinical practice for optimizing the effectiveness of these therapies.
Biomarker-Driven Patient Stratification Strategies
- Utilizing biomarkers to categorize patient subgroups for precision treatment
- Integrating multi-omics data and computational approaches in stratification
- Reviewing case studies highlighting successful patient stratification in innate immune system therapies
Evaluating Treatment Response via Biomarker Analysis
- Biomarker-driven assessment of treatment efficacy and response in clinical settings
- Discussing advancements in imaging, liquid biopsy, and molecular techniques for response monitoring
- Overcoming challenges and limitations in interpreting biomarker-driven treatment response
Future Perspectives: Emerging Biomarkers & Integration into Clinical Practice
- Exploring novel biomarkers and technologies for refining patient stratification and response evaluation
- Gaining insight into regulatory considerations and standardization for biomarker incorporation in clinical trials
- The road ahead: Integrating biomarkers into routine clinical practice for innate immune system therapies
More speakers to be announced!
